Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,685 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S).
Niess AM, Widmann M, Gaidai R, Gölz C, Schubert I, Castillo K, Sachs JP, Bizjak D, Vollrath S, Wimbauer F, Vogel A, Keller K, Burgstahler C, Quermann A, Kerling A, Schneider G, Zacher J, Diebold K, Grummt M, Beckendorf C, Buitenhuis J, Egger F, Venhorst A, Morath O, Barsch F, Mellwig KP, Oesterschlink J, Wüstenfeld J, Predel HG, Deibert P, Friedmann-Bette B, Mayer F, Hirschmüller A, Halle M, Steinacker JM, Wolfarth B, Meyer T, Böttinger E, Flechtner-Mors M, Bloch W, Haller B, Roecker K, Reinsberger C. Niess AM, et al. Among authors: vogel a. Int J Public Health. 2022 Feb 7;67:1604414. doi: 10.3389/ijph.2022.1604414. eCollection 2022. Int J Public Health. 2022. PMID: 35197815 Free PMC article.
COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance-A Prospective, Observational, Multicenter Cohort Study (CoSmo-S).
Widmann M, Gaidai R, Schubert I, Grummt M, Bensen L, Kerling A, Quermann A, Zacher J, Vollrath S, Bizjak DA, Beckendorf C, Egger F, Hasler E, Mellwig KP, Fütterer C, Wimbauer F, Vogel A, Schoenfeld J, Wüstenfeld JC, Kastner T, Barsch F, Friedmann-Bette B, Bloch W, Meyer T, Mayer F, Wolfarth B, Roecker K, Reinsberger C, Haller B, Niess AM; CoSmo-S Consortium. Widmann M, et al. Among authors: vogel a. Sports Med. 2024 Apr;54(4):1033-1049. doi: 10.1007/s40279-023-01976-0. Epub 2024 Jan 11. Sports Med. 2024. PMID: 38206445 Free PMC article.
Rationale and design of the CRAFT (Continuous ReAssessment with Flexible ExTension in Rare Malignancies) multicenter phase II trial.
Heilig CE, Horak P, Kreutzfeldt S, Teleanu V, Mock A, Renner M, Bhatti IA, Hutter B, Hüllein J, Fröhlich M, Uhrig S, Süße H, Heiligenthal L, Ochsenreither S, Illert AL, Vogel A, Desuki A, Heinemann V, Heidegger S, Bitzer M, Scheytt M, Brors B, Hübschmann D, Baretton G, Stenzinger A, Steindorf K, Benner A, Jäger D, Heining C, Glimm H, Fröhling S, Schlenk RF. Heilig CE, et al. Among authors: vogel a. ESMO Open. 2021 Dec;6(6):100310. doi: 10.1016/j.esmoop.2021.100310. Epub 2021 Nov 20. ESMO Open. 2021. PMID: 34808524 Free PMC article.
Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease.
Morison LD, Whiteman IT, Vogel AP, Tilbrook L, Fahey MC, Braden R, Bredebusch J, Hildebrand MS, Scheffer IE, Morgan AT. Morison LD, et al. Among authors: vogel ap. J Inherit Metab Dis. 2025 Jan;48(1):e12838. doi: 10.1002/jimd.12838. J Inherit Metab Dis. 2025. PMID: 39821609 Free PMC article.
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka T, Gerolami R, Ikeda M, Kumada H, El-Khoueiry AB, Vogel A, Peng X, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS, Llovet JM; LEAP-012 investigators. Kudo M, et al. Among authors: vogel a. Lancet. 2025 Jan 18;405(10474):203-215. doi: 10.1016/S0140-6736(24)02575-3. Epub 2025 Jan 8. Lancet. 2025. PMID: 39798578 Clinical Trial.
Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.
Xia D, Bai W, Wang Q, Chung JW, Adhoute X, Kloeckner R, Zhang H, Zeng Y, Sripongpun P, Nie C, Kim SU, Huang M, Hu W, Ding X, Yin G, Li H, Zhao H, Bronowicki JP, Li J, Li J, Zhu X, Wu J, Zhang C, Gong W, Li Z, Lin Z, Xu T, Yin T, Anty R, Song J, Shi H, Shao G, Ren W, Zhang Y, Yang S, Zheng Y, Xu J, Wang W, Zhu X, Fu Y, Liu C, Kaewdech A, Ding R, Zheng J, Liu S, Yu H, Zheng L, You N, Fan W, Zhang S, Feng L, Wang G, Zhang P, Li X, Chen J, Zhang F, Shao W, Zhou W, Zeng H, Cao G, Huang W, Jiang W, Zhang W, Li L, Feng A, Wang E, Wang Z, Han D, Lv Y, Sun J, Ren B, Xia L, Li X, Yuan J, Wang Z, Luo B, Li K, Guo W, Yin Z, Zhao Y, Xia J, Fan D, Wu K, Bettinger D, Vogel A, Han G; China HCC-TACE study group. Xia D, et al. Among authors: vogel a. JHEP Rep. 2024 Sep 12;7(1):101216. doi: 10.1016/j.jhepr.2024.101216. eCollection 2025 Jan. JHEP Rep. 2024. PMID: 39758510 Free PMC article.
The use of immunotherapy pre-liver transplant.
Aceituno L, Gravely AK, O'Kane GM, Vogel A, Sapisochin G. Aceituno L, et al. Among authors: vogel a. J Hepatol. 2025 Jan 3:S0168-8278(24)02702-8. doi: 10.1016/j.jhep.2024.11.005. Online ahead of print. J Hepatol. 2025. PMID: 39755438 No abstract available.
1,685 results